NMR-based metabolomics for identification of α-amylase inhibitors in rowan berries (Sorbus spp.)

Sofie L. Broholm, Simone Gramsbergen, Nils Nyberg, Anna Jäger, Dan Stærk

    936 Downloads (Pure)

    Abstract

    Type 2 diabetes is a metabolic disorder estimated to affect millions of people all over the world.1 One way of reducing diabetes-related complications is to control
    postprandial glucose.2 Inhibition of the carbohydrate digestive enzyme α-amylase is a therapeutic target for maintaining low blood glucose levels. A study from 2011
    shows that berries from Sorbus spp (rowan berries) effectively inhibit α-amylase activity and suggests that the active compounds are proanthocyanidins.3 The aim of this
    project is to identify the rowan berry species with highest α-amylase inhibitory activity - and to find a 1H-NMR method suitable for NMR-based metabolomics
    Original languageEnglish
    Publication date2015
    Number of pages1
    Publication statusPublished - 2015
    Event36th Danish NMR Meeting - Lund, Sweden
    Duration: 19 Jan 201520 Jan 2015

    Conference

    Conference36th Danish NMR Meeting
    Country/TerritorySweden
    CityLund
    Period19/01/201520/01/2015

    Fingerprint

    Dive into the research topics of 'NMR-based metabolomics for identification of α-amylase inhibitors in rowan berries (Sorbus spp.)'. Together they form a unique fingerprint.

    Cite this